Use of FAAH Inhibitors for Treating Parkinson's Disease and Restless Legs Syndrome
The present disclosure relates to methods of using fatty acid amide hydrolase (FAAH) inhibitors to treat aspects of Parkinson's disease (PD), restless legs syndrome (RLS) and periodic limb movement disorder (PLMD), the use of FAAH inhibitors for the manufacture of medicaments for use in the tre...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English |
Published |
13.06.2013
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The present disclosure relates to methods of using fatty acid amide hydrolase (FAAH) inhibitors to treat aspects of Parkinson's disease (PD), restless legs syndrome (RLS) and periodic limb movement disorder (PLMD), the use of FAAH inhibitors for the manufacture of medicaments for use in the treatment of PD, RLS and PLMD, as well as pharmaceutically acceptable compositions comprising FAAH inhibitors for use in the treatment of PD, RLS and PLMD. |
---|---|
AbstractList | The present disclosure relates to methods of using fatty acid amide hydrolase (FAAH) inhibitors to treat aspects of Parkinson's disease (PD), restless legs syndrome (RLS) and periodic limb movement disorder (PLMD), the use of FAAH inhibitors for the manufacture of medicaments for use in the treatment of PD, RLS and PLMD, as well as pharmaceutically acceptable compositions comprising FAAH inhibitors for use in the treatment of PD, RLS and PLMD. |
Author | PEARSON JAMES PHILIP BROTCHIE JONATHAN MICHAEL MILNE TODD G JOHNSTON THOMAS HENRY |
Author_xml | – fullname: JOHNSTON THOMAS HENRY – fullname: PEARSON JAMES PHILIP – fullname: BROTCHIE JONATHAN MICHAEL – fullname: MILNE TODD G |
BookMark | eNqNyzkOwjAQQFEXULDdYSQKKqQYA30EREGiQFnqyJBxsAgzkccNt4eCA1D95v2pGhETTlRRCwI7yNI0hzM9_M1HDgKOA1QBbfTUwdWGpydhWgkcvaD9PpZaKFBijyJwwU6gfFMb-IVzNXa2F1z8OlPL7FQd8jUO3KAM9o6EsanLTaKN3iVmu0-1-U99AGPnOWA |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
ExternalDocumentID | US2013150346A1 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_US2013150346A13 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 15:35:00 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_US2013150346A13 |
Notes | Application Number: US201113520644 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20130613&DB=EPODOC&CC=US&NR=2013150346A1 |
ParticipantIDs | epo_espacenet_US2013150346A1 |
PublicationCentury | 2000 |
PublicationDate | 20130613 |
PublicationDateYYYYMMDD | 2013-06-13 |
PublicationDate_xml | – month: 06 year: 2013 text: 20130613 day: 13 |
PublicationDecade | 2010 |
PublicationYear | 2013 |
RelatedCompanies | PEARSON JAMES PHILIP IRONWOOD PHARMACEUTICAL, INC BROTCHIE JONATHAN MICHAEL MILNE TODD G JOHNSTON THOMAS HENRY |
RelatedCompanies_xml | – name: BROTCHIE JONATHAN MICHAEL – name: MILNE TODD G – name: JOHNSTON THOMAS HENRY – name: IRONWOOD PHARMACEUTICAL, INC – name: PEARSON JAMES PHILIP |
Score | 2.9001982 |
Snippet | The present disclosure relates to methods of using fatty acid amide hydrolase (FAAH) inhibitors to treat aspects of Parkinson's disease (PD), restless legs... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
Title | Use of FAAH Inhibitors for Treating Parkinson's Disease and Restless Legs Syndrome |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20130613&DB=EPODOC&locale=&CC=US&NR=2013150346A1 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEL8QNOqbokYUTRPNfFoENrb5QAxsLGgUCDDDG9nHDUlMR-yM_77XMpQn3ppe0rSXXu9-vS-AO8RWbKFV18M0jHTTSFp6SPdETxyTIG5YTwjNyWiLgdUPzJdZa1aCz00ujKoT-qOKI5JExSTvuXqvV_-fWJ6KrRQP0ZKmsid_2va0Ah3Tg0zqSfO67d5o6A1dzXXbwUQbjBWNbB_DtDqElfakIS0r7ffeuzIvZbWtVPxj2B_Rejw_gRLyChy6m95rFTh4K1zeNCykT5zCOBDIspT5nU6fPfOPZbSUvXIY2Z1sqow_vmAyjVlldN0L5q29LyzkCRujdOgKwV5xIdikKFRwBrd-b-r2ddrc_I8X82CyfRLjHMo843gBzEbHNjB24thE89GyCUZh6tip0yAVVW-GVajtWulyN_kKjprrPhB6w6hBOf_6xmvSxnl0o5j4C8-7jZg |
link.rule.ids | 230,309,786,891,25594,76903 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEL8QNOKbokYUtYlmPi0CG9t8WMzYWIbyFdgMb2QfHZKYQuyM_763MpQn3ppe0rSXXu9-vS-AB0rbsUa1hhymYSSrStKWQ7wncmKoCHHDRoJoLo-2GGpeoL7O2rMSfG5zYUSd0B9RHBElKkZ5z8R7vf7_xHJEbCV_ipY4tXpxfdORCnSMDzKqJ8npmN3xyBnZkm2bwVQaTgQNbR9F1SzESgc6gkIBlt47eV7KelepuCdwOMb1WHYKJcqqULG3vdeqcDQoXN44LKSPn8Ek4JSsUuJalkd67GMZLfNeOQTtTuIL448tSJ7GLDK6HjlxNt4XErKETGju0OWc9OmCk2lRqOAc7t2ub3sybm7-x4t5MN09iXIBZbZi9BKITg1dobERxypVnzUdYRRNDT01mqiiGq2wBvV9K13tJ99BxfMH_Xm_N3y7huPWpieE3FTqUM6-vukNauYsuhUM_QWUIJCC |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Use+of+FAAH+Inhibitors+for+Treating+Parkinson%27s+Disease+and+Restless+Legs+Syndrome&rft.inventor=JOHNSTON+THOMAS+HENRY&rft.inventor=PEARSON+JAMES+PHILIP&rft.inventor=BROTCHIE+JONATHAN+MICHAEL&rft.inventor=MILNE+TODD+G&rft.date=2013-06-13&rft.externalDBID=A1&rft.externalDocID=US2013150346A1 |